Voinosis secured the lone Startup Battlefield 200 berth at DETO 2026 after beating eight other South Korean startups pitching for a place at next year’s TechCrunch Disrupt competition.
The Seoul startup uses AI to analyze pitch, pauses, rhythm and response times in under five minutes, and says a 146-participant clinical study showed 88% accuracy in screening for potential cognitive issues.
Grace Shin, an otologic surgeon with more than 25 years of experience, founded Voinosis to sell the tool to hospitals, senior living facilities, insurers and consumers, with plans to pair voice checks with clinician-led treatment.
All nine DETO finalists are pursuing U.S. expansion, while Voinosis is raising a Series A round and has already brought in a South Korean pharmaceutical company as a strategic investor.